Keyphrases
Virological Failure
100%
Abacavir
100%
Nevirapine
100%
Salvage Therapy
100%
Nevirapine Resistance
100%
Genetic Resistance
50%
Protease Inhibitors
37%
Resistance Development
25%
Lamivudine
25%
Zidovudine
25%
Direct Sequencing
12%
Previous Treatment
12%
HIV Viral Load
12%
Viral Load
12%
Transient Reduction
12%
Plasma Viral Load
12%
Nucleoside Reverse Transcriptase Inhibitors
12%
Transient Effect
12%
Recombinant Virus
12%
Cross-resistance
12%
Cell-associated DNA
12%
Heavily Pretreated Patients
12%
Virus Assay
12%
Reverse Transcriptase Inhibitors
12%
Basal Resistance
12%
Medicine and Dentistry
Salvage Therapy
100%
Abacavir
100%
Nevirapine
100%
Human Immunodeficiency Virus
33%
Proteinase Inhibitor
33%
Reverse-Transcriptase Inhibitor
22%
Cross Resistance
11%
Virus Recombinant
11%
Lamivudine/Zidovudine
11%
Abacavir/Lamivudine/Zidovudine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nevirapine
100%
Abacavir
100%
HIV
33%
Proteinase Inhibitor
33%
RNA Directed DNA Polymerase Inhibitor
22%
Lamivudine Plus Zidovudine
11%
Cross-Resistance
11%
Abacavir Plus Lamivudine Plus Zidovudine
11%